CIS
TMO icon

Capital International Sarl’s Thermo Fisher Scientific TMO Stock Holding History

Capital International Sarl’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.8M Sell
83,303
-6,111
-7% -$2.93M 0.59% 46
2026
Q1 		$43.9M Sell
89,414
-17,121
-16% -$9.29M 0.72% 43
2025
Q4 		$61.7M Buy
106,535
+7,317
+7% +$4.14M 0.99% 26
2025
Q3 		$48.1M Buy
99,218
+4,689
+5% +$2.18M 0.83% 32
2025
Q2 		$38.3M Sell
94,529
-2,178
-2% -$911K 0.74% 38
2025
Q1 		$48.1M Buy
96,707
+27,426
+40% +$14.9M 1.09% 22
2024
Q4 		$36M Sell
69,281
-2,799
-4% -$1.54M 0.83% 31
2024
Q3 		$44.6M Buy
72,080
+9,992
+16% +$5.91M 1.15% 21
2024
Q2 		$34.3M Sell
62,088
-3,600
-5% -$2.06M 1.05% 25
2024
Q1 		$38.2M Buy
65,688
+12,151
+23% +$6.82M 1.27% 17
2023
Q4 		$28.4M Buy
53,537
+3,512
+7% +$1.7M 1.06% 20
2023
Q3 		$25.3M Buy
50,025
+3,491
+8% +$1.86M 1.16% 19
2023
Q2 		$24.3M Buy
46,534
+4,262
+10% +$2.3M 1.09% 17
2023
Q1 		$24.4M Buy
42,272
+4,309
+11% +$2.43M 1.23% 14
2022
Q4 		$20.9M Buy
37,963
+5,873
+18% +$3.11M 1.47% 9
2022
Q3 		$16.3M Buy
32,090
+2,848
+10% +$1.59M 1.31% 13
2022
Q2 		$15.9M Buy
29,242
+3,790
+15% +$2.09M 1.27% 14
2022
Q1 		$15M Buy
25,452
+4,124
+19% +$2.37M 0.75% 34
2021
Q4 		$14.2M Buy
21,328
+17,019
+395% +$10.6M 0.68% 40
2021
Q3 		$2.46M Sell
4,309
-262
-6% -$144K 0.22% 117
2021
Q2 		$2.31M Buy
4,571
+366
+9% +$173K 0.2% 127
2021
Q1 		$1.92M Buy
4,205
+171
+4% +$81.6K 0.18% 128
2020
Q4 		$1.88M Buy
4,034
+414
+11% +$194K 0.2% 117
2020
Q3 		$1.6M Sell
3,620
-340
-9% -$140K 0.2% 108
2020
Q2 		$1.44M Buy
3,960
+1,114
+39% +$373K 0.19% 111
2020
Q1 		$807K Buy
2,846
+141
+5% +$44.5K 0.15% 124
2019
Q4 		$879K Buy
+2,705
New +$820K 0.14% 129

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Sarl's TMO Position: Q2 2026 in Review

Capital International Sarl reduced its Thermo Fisher Scientific (TMO) stake by 6.8% in Q2 2026, selling an estimated $2.93M and leaving 83,303 shares worth $41.8M. The position accounts for 0.59% of the portfolio, ranked #46.

Capital International Sarl first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $61.7M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital International Sarl held 83,303 shares of Thermo Fisher Scientific worth $41.8M as of Q2 2026.
  • Capital International Sarl sold 6,111 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.93M.
  • Thermo Fisher Scientific made up 0.59% of Capital International Sarl's portfolio in Q2 2026, its #46 holding.
  • Capital International Sarl first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Capital International Sarl's Thermo Fisher Scientific position peaked at $61.7M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.